Simbiose, Bioma, Biagro, Biograss, and Biojet are combining industrial capacity, R&D expertise, and application technology, while targeting the global market.

In today’s statement, Cogny said that it was creating a new model for the biological crop protection sector, offering a “one-stop solution” for agriculture’s demands.

“Cogny is the largest ecosystem dedicated to agricultural microbiology in the world today. These are companies 100% focused on delivering biological solutions in inputs, application equipment, and seeds with embedded technology, plus our own research centre,” explains Luiz Felipe Fiorese, International Business Manager at Cogny. “No economic group in the world has three market-access brands operating this way.”

Brand names
At its commercial core are the Simbiose, Bioma, and Biagro brands, which serve distinct market channels and customer segments in Latin America. Together, the companies total nearly 300 registered technologies, which Cogny says is unparalleled within the Latin American bioinputs industry.

Simbiose operates with field development teams in Paraguay, while Biagro maintains more than 20 years of presence in the Argentine market. In Bolivia and Uruguay, the platform employs a multi-brand strategy, using both Simbiose and Bioma according to local market conditions.

Beyond traditional distribution channels, the new entity includes specialized companies that address critical delivery challenges. Biojet manufactures equipment that enables the application of biological inputs in the field via planting furrow, promoting ideal temperature conditions with a differentiated nozzle self-cleaning system.

The most recent addition, Biograss, is the seed brand, which employs embedded technology that carries the biological input to promote more biologically structured soil.

Industrial Capacity Meets Innovation
Cogny says its industrial infrastructure represents the largest microbiological production complex in global agribusiness. Four manufacturing units — three in Brazil and one in Argentina — provide production capacity for bacteria, viruses, and fungi within a single corporate structure.

The platform has a production capacity of more than 40 million kilos/litres per year and is currently undergoing expansions that will increase this number by 50%, reaching 60 million kilos/litres per year.

Additionally, Cogny says it represents the world’s largest liquid fermentation industrial complex. Its built area was expanded by more than 13,000 square meters, reaching 62,000 square meters. Furthermore, it has 17 distribution centres in Brazil.

“Generally, companies focus on bacteria, or bacteria and fungi, or sometimes just viruses,” explains Fiorese. “Having all three categories in the same economic group is not something easily found in the market. This brings us significant advantages in offering complete solutions — almost a one-stop shop where our clients, whether producers, cooperatives, distributors, or B2B partners, can find all the solutions they need within our ecosystem, whether microbiology, machinery, pasture seeds, or research.”

Cogny’s research capabilities are concentrated at Orygen Research — Brazil’s largest private microbiological Research and innovation Centre focused on agribusiness. The R&D process has more than 10 stages, from microorganism bioprospecting, through genetic sequencing, editing, and genetic insertion, to formulation for industrial scale and product registration.

Orygen Research has its own collection of microorganisms and achieved the NB-2 security level assigned by the National Technical Biosafety Commission (CTNBio) — a special certification for manipulations with genetically modified organisms with protection and safety at all stages of the process. For more than 15 years, this Research Centre has been developing microbiological technologies for companies in the Cogny Ecosystem.

International Expansion
Cogny’s international growth strategy employs multiple approaches adapted to different market conditions. Cogny offers as a notable example the distribution agreement with Corteva for the European Union market established last year.

In regions where Cogny has greater familiarity — including other American markets and Africa — Cogny operates with direct market presence, deploying field teams in countries where revenue volumes justify the investment, while maintaining distribution models in emerging markets.

“It’s a model with various strategies, depending very much on the viability of each country and the reality of each market we are serving,” explains Fiorese.

Financial projections
Cogny has ambitious financial projections, forecasting exponential growth over the next three to four years, transforming exports from a minor component to a substantial portion of total business. The strategy also emphasizes building revenue streams in developed market currencies, particularly dollars and euros, as part of long-term business planning.

Cogny will present its integrated capabilities at ABIM 2025, taking place October 20-22 in Basel, Switzerland.